These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3333296)

  • 21. [Cyclosporin A--new perspectives in transplantation surgery].
    Margreiter R; Huber C; Borel JF
    Wien Med Wochenschr; 1983; 133 Suppl 1():37-42. PubMed ID: 6362212
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological characteristics of cyclosporin A. Its use in kidney transplantation].
    Obukh IB
    Ter Arkh; 1988; 60(5):136-43. PubMed ID: 3051484
    [No Abstract]   [Full Text] [Related]  

  • 23. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
    Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cyclosporin A in cadaveric kidney transplantation. A randomized study].
    Griñó JM; Seron D; Castelao AM; Sabaté I; Gil-Vernet S; Andrés E; Sabater R; Franco E; Torras J; Alsina J
    Med Clin (Barc); 1988 May; 90(18):719-23. PubMed ID: 3050303
    [No Abstract]   [Full Text] [Related]  

  • 26. Contrasting results of immunological monitoring in cyclosporine- and azathioprine-treated renal allograft recipients.
    Waltzer WC; Arnold AN; Anaise D; Rapaport FT
    Transplant Proc; 1986 Aug; 18(4):970-3. PubMed ID: 3526668
    [No Abstract]   [Full Text] [Related]  

  • 27. Post-transplant glomerulonephritis under conventional and cyclosporin A immunosuppression.
    Yussim A; Ben-Bassat M; Shapira Z; Shmueli D; Shaharabani E; Lustig S; Nakache R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2119-20. PubMed ID: 2652684
    [No Abstract]   [Full Text] [Related]  

  • 28. [The diagnosis of cyclosporin nephrotoxicity in patients after kidney transplantation].
    Rozental' RL; Il'inskiĭ IM; Bitsans IaB; Strokan' VA
    Ter Arkh; 1990; 62(6):92-4. PubMed ID: 2218937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Nephrotoxicity' and metabolic acidosis in transplant patients on cyclosporin A.
    Hamilton DV; Evans DB; Henderson RG; Thiru S; Calne RY; White DJ; Carmichael DJ
    Proc Eur Dial Transplant Assoc; 1981; 18():400-9. PubMed ID: 7036160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of cyclosporin in experimental pancreas transplant].
    Prieto M; Sutherland DE; Fernández-Cruz L; Heil J; Najarian J
    Rev Quir Esp; 1988; 15(1):32-4. PubMed ID: 3153356
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of chronic renal cyclosporin-A toxicity.
    Klintmalm G
    Nephrologie; 1987; 8(3):131-3. PubMed ID: 3309701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kaposi's sarcoma in kidney transplant treated with cyclosporin and azathioprine].
    Cózar JM; Martínez Piñeiro L; Avellana JA; de la Peña J; Hidalgo L; Sanz A; Burgos F; Martínez Piñeiro JA
    Arch Esp Urol; 1990 Mar; 43(2):155-8. PubMed ID: 2363579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cyclosporin: experimental studies and clinical use in organ transplants].
    Araujo JL; Towpik E; Kupiec-Weglinski JW; Tilney NL
    Rev Invest Clin; 1984; 36(4):367-76. PubMed ID: 6396785
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cyclosporin in kidney transplantation].
    Land W; Castro LA; Hillebrand G; Klare B; Illner WD; Fornara P
    Internist (Berl); 1985 Sep; 26(9):549-52. PubMed ID: 3905675
    [No Abstract]   [Full Text] [Related]  

  • 35. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical problems in cyclosporine dosing with reference to clinical pharmacology: case histories and discussion.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):16-40. PubMed ID: 2662534
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
    First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680
    [No Abstract]   [Full Text] [Related]  

  • 38. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements.
    Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P
    Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cyclosporin A: a new immunosuppressive agent in renal transplantation].
    Martín RS; Thiel G; Brunner F
    Medicina (B Aires); 1985; 45(6):675-86. PubMed ID: 3916124
    [No Abstract]   [Full Text] [Related]  

  • 40. The current state of renal transplantation.
    Calne RY
    Kidney Int Suppl; 1986 Jul; 19():S23-4. PubMed ID: 3528620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.